Intra-Cellular Therapies | 10-Q:季度報表
Intra-Cellular Therapies | 8-K:細胞內療法公佈2024年第一季度財務業績
Intra-Cellular Therapies | ARS:年度報告
Intra-Cellular Therapies | DEFA14A:其他
Intra-Cellular Therapies | DEF 14A:股東委託書決議
Intra-Cellular Therapies | 4:持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 424B5:募資說明書
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 424B5:募資說明書
Intra-Cellular Therapies | S-3ASR:“知名成熟發行人”證券註冊聲明
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 4:持股變動聲明-董事 VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4:持股變動聲明-董事 RIGGS RORY B
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 4:持股變動聲明-董事 RIGGS RORY B
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 4:持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4:持股變動聲明-高管 Hineline Lawrence J.
暫無數據